The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Cefaseptin 300 mg tablets for dogs

300 mg/tablet Tablet

Vetoquinol Ireland LimitedVPA10983/044/002

Main Information

Trade NameCefaseptin 300 mg tablets for dogs
Active SubstancesCefalexin
Strength300 mg/tablet
Dosage FormTablet
Licence HolderVetoquinol Ireland Limited
Licence NumberVPA10983/044/002

Group Information

ATC CodeQJ01DB01 cefalexin
Therapeutic ClassAntibacterial


Licence Issued15/01/2016
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back